Recommendations for the use of biologic therapy in rheumatoid arthritis

update from the Italian Society for Rheumatology I. Efficacy.

Roberto Caporali, Fabrizio Conti, Stefano Alivernini, Fabiola Atzeni, Bruno Seriolo, Maurizio Cutolo, Guido Valesini, Gianfranco Ferraccioli, Piercarlo Sarzi-Puttini, Carlo Salvarani, Serena Guiducci, Giuseppe Zampogna, Elisa Gremese, Nicolo' Pipitone, Rossana Scrivo, Serena Bugatti, Carlomaurizio Montecucco, Marco Matucci-Cerinic, Society for Rheumatology Italian Society for Rheumatology

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Società Italiana di Reumatologia, SIR) decided to update its recommendations and, to this end, a systematic literature review was carried out and the evidence derived from it was discussed and summarised as expert opinions. Levels of evidence, strength of recommendations and levels of agreement were reported. The recommendations reported are intended to help prescribing rheumatologists to optimise the use of biologic agents in patients with RA seen in everyday practice; they are not to be considered as a regulatory rule.

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume29
Issue number3 Suppl 66
Publication statusPublished - May 2011

Fingerprint

Biological Therapy
Biological Factors
Rheumatology
Rheumatoid Arthritis
Drug Prescriptions
Expert Testimony
Rheumatologists
Therapeutics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Caporali, R., Conti, F., Alivernini, S., Atzeni, F., Seriolo, B., Cutolo, M., ... Italian Society for Rheumatology, S. F. R. (2011). Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clinical and Experimental Rheumatology, 29(3 Suppl 66).

Recommendations for the use of biologic therapy in rheumatoid arthritis : update from the Italian Society for Rheumatology I. Efficacy. / Caporali, Roberto; Conti, Fabrizio; Alivernini, Stefano; Atzeni, Fabiola; Seriolo, Bruno; Cutolo, Maurizio; Valesini, Guido; Ferraccioli, Gianfranco; Sarzi-Puttini, Piercarlo; Salvarani, Carlo; Guiducci, Serena; Zampogna, Giuseppe; Gremese, Elisa; Pipitone, Nicolo'; Scrivo, Rossana; Bugatti, Serena; Montecucco, Carlomaurizio; Matucci-Cerinic, Marco; Italian Society for Rheumatology, Society for Rheumatology.

In: Clinical and Experimental Rheumatology, Vol. 29, No. 3 Suppl 66, 05.2011.

Research output: Contribution to journalArticle

Caporali, R, Conti, F, Alivernini, S, Atzeni, F, Seriolo, B, Cutolo, M, Valesini, G, Ferraccioli, G, Sarzi-Puttini, P, Salvarani, C, Guiducci, S, Zampogna, G, Gremese, E, Pipitone, N, Scrivo, R, Bugatti, S, Montecucco, C, Matucci-Cerinic, M & Italian Society for Rheumatology, SFR 2011, 'Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.', Clinical and Experimental Rheumatology, vol. 29, no. 3 Suppl 66.
Caporali, Roberto ; Conti, Fabrizio ; Alivernini, Stefano ; Atzeni, Fabiola ; Seriolo, Bruno ; Cutolo, Maurizio ; Valesini, Guido ; Ferraccioli, Gianfranco ; Sarzi-Puttini, Piercarlo ; Salvarani, Carlo ; Guiducci, Serena ; Zampogna, Giuseppe ; Gremese, Elisa ; Pipitone, Nicolo' ; Scrivo, Rossana ; Bugatti, Serena ; Montecucco, Carlomaurizio ; Matucci-Cerinic, Marco ; Italian Society for Rheumatology, Society for Rheumatology. / Recommendations for the use of biologic therapy in rheumatoid arthritis : update from the Italian Society for Rheumatology I. Efficacy. In: Clinical and Experimental Rheumatology. 2011 ; Vol. 29, No. 3 Suppl 66.
@article{2b417aa310e745fbb5bd4c12047b29c9,
title = "Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.",
abstract = "Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Societ{\`a} Italiana di Reumatologia, SIR) decided to update its recommendations and, to this end, a systematic literature review was carried out and the evidence derived from it was discussed and summarised as expert opinions. Levels of evidence, strength of recommendations and levels of agreement were reported. The recommendations reported are intended to help prescribing rheumatologists to optimise the use of biologic agents in patients with RA seen in everyday practice; they are not to be considered as a regulatory rule.",
author = "Roberto Caporali and Fabrizio Conti and Stefano Alivernini and Fabiola Atzeni and Bruno Seriolo and Maurizio Cutolo and Guido Valesini and Gianfranco Ferraccioli and Piercarlo Sarzi-Puttini and Carlo Salvarani and Serena Guiducci and Giuseppe Zampogna and Elisa Gremese and Nicolo' Pipitone and Rossana Scrivo and Serena Bugatti and Carlomaurizio Montecucco and Marco Matucci-Cerinic and {Italian Society for Rheumatology}, {Society for Rheumatology}",
year = "2011",
month = "5",
language = "English",
volume = "29",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "3 Suppl 66",

}

TY - JOUR

T1 - Recommendations for the use of biologic therapy in rheumatoid arthritis

T2 - update from the Italian Society for Rheumatology I. Efficacy.

AU - Caporali, Roberto

AU - Conti, Fabrizio

AU - Alivernini, Stefano

AU - Atzeni, Fabiola

AU - Seriolo, Bruno

AU - Cutolo, Maurizio

AU - Valesini, Guido

AU - Ferraccioli, Gianfranco

AU - Sarzi-Puttini, Piercarlo

AU - Salvarani, Carlo

AU - Guiducci, Serena

AU - Zampogna, Giuseppe

AU - Gremese, Elisa

AU - Pipitone, Nicolo'

AU - Scrivo, Rossana

AU - Bugatti, Serena

AU - Montecucco, Carlomaurizio

AU - Matucci-Cerinic, Marco

AU - Italian Society for Rheumatology, Society for Rheumatology

PY - 2011/5

Y1 - 2011/5

N2 - Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Società Italiana di Reumatologia, SIR) decided to update its recommendations and, to this end, a systematic literature review was carried out and the evidence derived from it was discussed and summarised as expert opinions. Levels of evidence, strength of recommendations and levels of agreement were reported. The recommendations reported are intended to help prescribing rheumatologists to optimise the use of biologic agents in patients with RA seen in everyday practice; they are not to be considered as a regulatory rule.

AB - Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Società Italiana di Reumatologia, SIR) decided to update its recommendations and, to this end, a systematic literature review was carried out and the evidence derived from it was discussed and summarised as expert opinions. Levels of evidence, strength of recommendations and levels of agreement were reported. The recommendations reported are intended to help prescribing rheumatologists to optimise the use of biologic agents in patients with RA seen in everyday practice; they are not to be considered as a regulatory rule.

UR - http://www.scopus.com/inward/record.url?scp=80055068987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055068987&partnerID=8YFLogxK

M3 - Article

VL - 29

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3 Suppl 66

ER -